A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children
Clinical trial NCT01379937 · COMPLETED
Trial details
- NCT number
- NCT01379937
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-28
- Primary completion
- 2012-08-02
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.